statistiche ricercatore

Continente	#
NA - Nord America	482
AS - Asia	253
EU - Europa	250
Continente sconosciuto - Info sul continente non disponibili	51
SA - Sud America	39
AF - Africa	7
OC - Oceania	1
Totale	1.083

Nazione	#
US - Stati Uniti d'America	462
IT - Italia	126
SG - Singapore	117
CN - Cina	40
BR - Brasile	34
VN - Vietnam	33
RU - Federazione Russa	29
IN - India	20
IE - Irlanda	19
SE - Svezia	16
BD - Bangladesh	14
GB - Regno Unito	14
CA - Canada	8
DE - Germania	8
FR - Francia	7
FI - Finlandia	6
NL - Olanda	6
PL - Polonia	6
HK - Hong Kong	4
PK - Pakistan	4
TR - Turchia	4
CR - Costa Rica	3
EE - Estonia	3
EG - Egitto	3
MX - Messico	3
PH - Filippine	3
AR - Argentina	2
AT - Austria	2
EC - Ecuador	2
IQ - Iraq	2
JP - Giappone	2
KZ - Kazakistan	2
RS - Serbia	2
SV - El Salvador	2
UA - Ucraina	2
ZA - Sudafrica	2
AU - Australia	1
BS - Bahamas	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
DO - Repubblica Dominicana	1
ES - Italia	1
EU - Europa	1
HN - Honduras	1
HU - Ungheria	1
IL - Israele	1
KE - Kenya	1
KR - Corea	1
KW - Kuwait	1
LB - Libano	1
LT - Lituania	1
MO - Macao, regione amministrativa speciale della Cina	1
NP - Nepal	1
SA - Arabia Saudita	1
TH - Thailandia	1
UY - Uruguay	1
VC - Saint Vincent e Grenadine	1
Totale	1.033

Nome	#
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival	156
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival	153
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival	145
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality	105
Nanomedicine for cancer patient-centered care	101
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome	101
Prevention of prostate cancer metastasis by a CRISPR-delivering nanoplatform for interleukin-30 genome editing	99
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs	96
Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways	95
Interleukin-30 promotes melanoma spreading and triggers LAG-3 expression and T cell exhaustion	25
Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs	7
Totale	1.083

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	16	0	0	0	0	3	5	2	0	1	0	2	3
2022/2023	90	4	11	2	5	6	13	1	6	13	22	7	0
2023/2024	51	3	5	2	0	0	14	10	9	0	1	0	7
2024/2025	199	7	12	28	18	8	10	18	21	10	18	21	28
2025/2026	516	46	18	36	51	50	24	78	32	52	66	39	24
2026/2027	204	22	22	44	91	25	0	0	0	0	0	0	0
Totale													1.083